• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为纤溶酶原激活物抑制剂-1(PAI-1)抑制剂的紫铆素类似物的设计、合成及构效关系研究

Design, synthesis, and SAR of embelin analogues as the inhibitors of PAI-1 (plasminogen activator inhibitor-1).

作者信息

Chen Fanglei, Zhang Guiping, Hong Zebin, Lin Zhonghui, Lei Min, Huang Mingdong, Hu Lihong

机构信息

Shanghai Research Center for the Modernization of Traditional Chinese Medicine, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, PR China.

State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, PR China.

出版信息

Bioorg Med Chem Lett. 2014 May 15;24(10):2379-82. doi: 10.1016/j.bmcl.2014.03.045. Epub 2014 Mar 24.

DOI:10.1016/j.bmcl.2014.03.045
PMID:24731276
Abstract

The natural product embelin was found to have PAI-1 inhibitory activity with the IC50 value of 4.94μM. Based on the structure of embelin, a series of analogues were designed, synthesized, and evaluated for their ability to inhibit PAI-1. The SAR study on these compounds disclosed that the inhibitory potency largely depended on the hydroxyl groups at C2 and C5, and the length of the alkyl chains at C3 and C6. Compound 11 displayed the best PAI-1 inhibitory potency with the IC50 value of 0.18μM.

摘要

天然产物紫铆因被发现具有PAI-1抑制活性,IC50值为4.94μM。基于紫铆因的结构,设计、合成了一系列类似物,并对其抑制PAI-1的能力进行了评估。对这些化合物的构效关系研究表明,抑制效力很大程度上取决于C2和C5位的羟基以及C3和C6位烷基链的长度。化合物11表现出最佳的PAI-1抑制效力,IC50值为0.18μM。

相似文献

1
Design, synthesis, and SAR of embelin analogues as the inhibitors of PAI-1 (plasminogen activator inhibitor-1).作为纤溶酶原激活物抑制剂-1(PAI-1)抑制剂的紫铆素类似物的设计、合成及构效关系研究
Bioorg Med Chem Lett. 2014 May 15;24(10):2379-82. doi: 10.1016/j.bmcl.2014.03.045. Epub 2014 Mar 24.
2
Structural insight into inactivation of plasminogen activator inhibitor-1 by a small-molecule antagonist.小分子拮抗剂使纤溶酶原激活物抑制剂-1失活的结构解析
Chem Biol. 2013 Feb 21;20(2):253-61. doi: 10.1016/j.chembiol.2013.01.002.
3
Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.通过定点诱变鉴定1型纤溶酶原激活物抑制剂低分子量抑制剂的结合位点。
Biochemistry. 1998 Feb 3;37(5):1227-34. doi: 10.1021/bi971554q.
4
Synthesis and SAR of 2-carboxylic acid indoles as inhibitors of plasminogen activator inhibitor-1.作为纤溶酶原激活物抑制剂-1抑制剂的2-羧酸吲哚的合成及构效关系
Bioorg Med Chem Lett. 2005 Aug 1;15(15):3514-8. doi: 10.1016/j.bmcl.2005.05.095.
5
Synthesis and Biological Activity of Embelin and its Derivatives: An Overview.恩贝醇及其衍生物的合成与生物活性:概述。
Mini Rev Med Chem. 2020;20(5):396-407. doi: 10.2174/1389557519666191015202723.
6
Design, synthesis, and evaluation of orally active inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.纤溶酶原激活物抑制剂-1(PAI-1)生成的口服活性抑制剂的设计、合成及评估
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6419-22. doi: 10.1016/j.bmcl.2008.10.067. Epub 2008 Oct 19.
7
Evaluation of pyrrolin-2-one derivatives synthesized by a new practical method as inhibitors of plasminogen activator inhibitor-1 (PAI-1).评价一种新实用方法合成的吡咯啉-2-酮衍生物作为纤溶酶原激活物抑制剂-1(PAI-1)抑制剂的效果。
Bioorg Med Chem Lett. 2010 Jan 15;20(2):546-8. doi: 10.1016/j.bmcl.2009.11.102. Epub 2009 Nov 23.
8
Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors.新型棓酚衍生物作为 CK2 抑制剂的设计、合成与生物评价。
Bioorg Chem. 2020 Jan;95:103520. doi: 10.1016/j.bioorg.2019.103520. Epub 2019 Dec 18.
9
Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein.新型紫铆因衍生物作为X连锁凋亡抑制蛋白有效抑制剂的设计、合成与表征
Bioorg Med Chem Lett. 2006 Nov 15;16(22):5805-8. doi: 10.1016/j.bmcl.2006.08.072. Epub 2006 Sep 8.
10
Development of inhibitors of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1抑制剂的研发
Methods Enzymol. 2011;501:177-207. doi: 10.1016/B978-0-12-385950-1.00009-2.

引用本文的文献

1
In situ protein corona-camouflaged supramolecular assemblies remodel thrombotic microenvironment for improved arterial homeostasis.原位蛋白质冠层伪装的超分子组装体重塑血栓形成微环境以改善动脉内稳态。
Sci Adv. 2025 May 2;11(18):eadu6676. doi: 10.1126/sciadv.adu6676.
2
Demystifying the Potential of Embelin-Loaded Nanoformulations: a Comprehensive Review.解析榄香素载药纳米制剂的潜力:全面综述。
AAPS PharmSciTech. 2024 Oct 21;25(8):249. doi: 10.1208/s12249-024-02968-7.
3
Medicinal potential of embelin and its nanoformulations: An update on the molecular mechanism and various applications.
紫铆因及其纳米制剂的药用潜力:分子机制及各种应用的最新进展
Iran J Basic Med Sci. 2024;27(10):1228-1242. doi: 10.22038/ijbms.2024.77888.16850.
4
Embelin and Its Derivatives: Design, Synthesis, and Potential Delivery Systems for Cancer Therapy.岩白菜素及其衍生物:癌症治疗的设计、合成与潜在递送系统
Pharmaceuticals (Basel). 2022 Sep 9;15(9):1131. doi: 10.3390/ph15091131.
5
Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone.计算研究揭示了醌衍生物抑制 SARS-CoV-2 的机制。研究了安石榴素和两种有治疗意义的化合物,即甲泼尼龙和地塞米松。
J Infect Public Health. 2020 Dec;13(12):1868-1877. doi: 10.1016/j.jiph.2020.09.015. Epub 2020 Oct 14.
6
Embelin as Lead Compound for New Neuroserpin Polymerization Inhibitors.作为新型神经丝氨酸蛋白酶聚合抑制剂先导化合物的岩白菜素
Life (Basel). 2020 Jul 11;10(7):111. doi: 10.3390/life10070111.